BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18195117)

  • 1. Inflammation and atrial fibrillation: cause or effect?
    Boos CJ; Lip GY
    Heart; 2008 Feb; 94(2):133-4. PubMed ID: 18195117
    [No Abstract]   [Full Text] [Related]  

  • 2. [C-reactive protein and atrial fibrillation. An old marker looking for a new target].
    Hernández Madrid A
    Rev Esp Cardiol; 2006 Feb; 59(2):94-8. PubMed ID: 16540029
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of inflammation on the development, successful cardioversion, recurrence and/or perpetuation of atrial fibrillation.
    Turhan H; Aksoy Y; Yetkin E; Kosar F
    Int J Cardiol; 2007 May; 118(2):256-7; author reply 258-61. PubMed ID: 17034885
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardioversion for atrial fibrillation: does inflammation matter?
    Watson T; Kakar P; Lip GY
    Am J Cardiol; 2007 Jun; 99(11):1617-8. PubMed ID: 17531593
    [No Abstract]   [Full Text] [Related]  

  • 5. C-reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation?
    Sata N; Hamada N; Horinouchi T; Amitani S; Yamashita T; Moriyama Y; Miyahara K
    Jpn Heart J; 2004 May; 45(3):441-5. PubMed ID: 15240964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The contribution of inflammatory process in pathogenesis and natural history of atrial fibrillation].
    Zyśko D; Gajek J; Mazurek W
    Pol Merkur Lekarski; 2005 Feb; 18(104):227-8. PubMed ID: 17877137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and anti-inflammatory interventions in atrial fibrillation.
    Korantzopoulos P; Kolettis TM; Kountouris E
    Int J Cardiol; 2005 Oct; 104(3):361-2. PubMed ID: 16087256
    [No Abstract]   [Full Text] [Related]  

  • 8. Inflammation and C-reactive protein in atrial fibrillation: cause or effect?
    Galea R; Cardillo MT; Caroli A; Marini MG; Sonnino C; Narducci ML; Biasucci LM
    Tex Heart Inst J; 2014 Oct; 41(5):461-8. PubMed ID: 25425976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-8 and atrial fibrillation.
    Melenovsky V; Lip GY
    Europace; 2008 Jul; 10(7):784-5. PubMed ID: 18523030
    [No Abstract]   [Full Text] [Related]  

  • 10. Predicting atrial fibrillation recurrence with circulating inflammatory markers in patients in sinus rhythm at high risk for atrial fibrillation: data from the GISSI atrial fibrillation trial.
    Masson S; Aleksova A; Favero C; Staszewsky L; Bernardinangeli M; Belvito C; Cioffi G; Sinagra G; Mazzone C; Bertocchi F; Vago T; Peri G; Cuccovillo I; Masuda N; Barlera S; Mantovani A; Maggioni AP; Franzosi MG; Disertori M; Latini R;
    Heart; 2010 Dec; 96(23):1909-14. PubMed ID: 20965978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation: another potential mechanism between diabetes mellitus and atrial fibrillation.
    Liu T; Li G
    Am J Cardiol; 2008 Jun; 101(11):1681-2. PubMed ID: 18489956
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion.
    Henningsen KM; Therkelsen SK; Bruunsgaard H; Krabbe KS; Pedersen BK; Svendsen JH
    Scand J Clin Lab Invest; 2009; 69(3):425-32. PubMed ID: 19204850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-18 among atrial fibrillation patients in the absence of structural heart disease.
    Luan Y; Guo Y; Li S; Yu B; Zhu S; Li S; Li N; Tian Z; Peng C; Cheng J; Li Q; Cui J; Tian Y
    Europace; 2010 Dec; 12(12):1713-8. PubMed ID: 20833691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative serum inflammatory response and the development of atrial fibrillation after coronary artery bypass surgery.
    Cosgrave J; Foley JB; Kelly R; McGovern E; Bennett K; Young V; Tolan M; Crean P; Kelleher D; Walsh MJ
    Heart; 2005 Nov; 91(11):1475-6. PubMed ID: 16230451
    [No Abstract]   [Full Text] [Related]  

  • 15. Source of inflammatory markers in patients with atrial fibrillation.
    Liuba I; Ahlmroth H; Jonasson L; Englund A; Jönsson A; Säfström K; Walfridsson H
    Europace; 2008 Jul; 10(7):848-53. PubMed ID: 18523031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein but not atrial dysfunction predicts recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.
    Lombardi F; Tundo F; Belletti S; Mantero A; Melzi D'eril GV
    J Cardiovasc Med (Hagerstown); 2008 Jun; 9(6):581-8. PubMed ID: 18475126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriasis, inflammation, and atrial fibrillation.
    Liu T; Li G
    Am J Cardiol; 2008 Sep; 102(5):647. PubMed ID: 18721531
    [No Abstract]   [Full Text] [Related]  

  • 18. Can perioperative C-reactive protein and interleukin-6 levels predict atrial fibrillation after coronary artery bypass surgery?
    Ziabakhsh-Tabari S
    Saudi Med J; 2008 Oct; 29(10):1429-31. PubMed ID: 18946567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation and inflammation: quest for the missing link in the etiopathogenesis of AF.
    Dixit S
    Heart Rhythm; 2010; 7(2):155-6. PubMed ID: 20022817
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of anticoagulant and anti-inflammatory responses using enoxaparin versus unfractionated heparin for transesophageal echocardiography-guided cardioversion of atrial fibrillation.
    Hoppensteadt D; Fareed J; Klein AL; Jasper SE; Apperson-Hansen C; Lieber EA; Katz WE; Malouf JF; Stoddard MF; Pape LA;
    Am J Cardiol; 2008 Oct; 102(7):842-6. PubMed ID: 18805108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.